BiotechTube
Home/Bolden Therapeutics/Ashley E. Webb, PhD
AE

Ashley E. Webb, PhD

Scientific Founder, SAB Member

Bolden Therapeutics

Therapeutic Areas

NeurologyPsychiatry

Bolden Therapeutics Pipeline

DrugIndicationPhase
Neurogenesis PlatformMultiple Neurological Disorders (Alzheimer's, Stroke, Depression, etc.)Pre-clinical

Leadership Team at Bolden Therapeutics

JP
Johnny Page, ScM
Co-Founder & CEO
CP
Charles Polsky, MD
Executive Chairman
AV
Anne Valat, PhD
Director of Research
JR
Justin R. Fallon, PhD
Scientific Founder, SAB Chair
View full Bolden Therapeutics profile